Unity Biotechnology Inc Reports Results For The Quarter Ended In September: Earnings Summary

Unity Biotechnology

10/11/2021 14:41

* UNITY Biotechnology Inc  UBX.OQ  reported a quarterly adjusted
loss of 30 cents​​ per share for the quarter ended in September.
The mean expectation of six analysts for the quarter was for a
loss of 37 cents per share.
* Reported revenue was zero​;  analysts expected zero. 
* UNITY Biotechnology Inc's reported EPS for the quarter was a
loss of 30 cents​.
* The mean earnings estimate of analysts had fallen by
about 3.2% in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* UNITY Biotechnology Inc shares had fallen by 14.3% this
quarter and lost 51.0% so far this year.
* The company reported a quarterly loss of $16.45 million.
* Wall Street's median 12-month price target for UNITY
Biotechnology Inc is $5.00 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 4 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell." 
This summary was machine generated November 10 at 02:41 p.m.
 ​All figures in US dollars unless otherwise stated